News

The acclaimed television presenter, producer and author has lent her support after revealing her son’s brain tumour diagnosis

Results from a phase 1 clinical trial, testing a drug called CLR 124, demonstrates its ability to cross the blood-brain barrier

Celebrated classical singer, Russell Watson, having had a brain tumour diagnosis in 2006, uses his upcoming tour to support our strategy

We are thrilled to announce our first ever awards, recognising those in the brain tumour community who are leading the way in support, awareness and vital research

Researchers design immune cells to target a protein found on two thirds of glioblastomas, the most common and lethal primary brain tumour

We’re thrilled to be working in partnership with CDM London, one of the world’s most admired healthcare advertising agencies.

Conditions were perfect for the first day of the ascent. The four-day challenge will test all skiers to their limits, ascending over 2,500 metres every day to reach their target

A European research collaboration is developing a new “laboratory on a chip” device that will be able to rapidly detect the different types of cancer stem cells involved in two of the most aggressive brain tumours

Every family affected by a brain tumour was promised “action not words” today at a landmark meeting in the battle to defeat brain tumours

The Government has today called for greater innovation in brain tumour research, as it publishes a landmark review into brain cancer research in the UK

We will voice the hope and determination of everyone in our community today when we join government ministers, fellow campaigners and researchers at a crucial meeting today in the battle against brain tumours

Tanya Ritchie, whose five-year-old son Toby, has a low grade brain tumour, heads up Toby’s Team, along with six other teams, who’ll take on this epic challenge on Monday to raise funds for vital research into childhood brain tumours

New research shows that an immunotherapy called CAR-T cell therapy—currently only effective in treating blood cancer—has the potential to treat solid tumours, such as brain tumours

Our Chief Executive, Sarah Lindsell, and our Chief Scientific Officer, David Jenkinson, will be among global brain tumour experts and campaigners meeting government ministers later this month to discuss progress against brain tumours

Date night ideas whether you’re suffering with brain tumour-related fatigue, a lack of money, or just a plain lack of ideas.

When one person is diagnosed with a brain tumour, maintaining a relationship can be difficult.

Paralysed dad of three, Simon Kindleysides, has stepped up his marathon training in the revolutionary ReWalk exo-suit

TV presenter Phil Spencer prepares to take on the Everest in the Alps expedition to raise funds for life-saving research into childhood brain tumours

A phase 2 clinical trial testing an immunotherapy drug called ipilimumab to treat patients with glioblastomas has been announced in the United Kingdom

Proud to announce our innovative charity partnership with Sulla Investment

On 6 March, we’re hosting a unique opportunity to get your research questions answered as our Scientific Advisory Board comes together from across the globe

Results of two phase 2 clinical trials testing cabozantinib suggest that anti-angiogenic therapy could be used to treat glioblastomas

Here at The Brain Tumour Charity we’re always learning, so when Professor David Walker came for an unannounced visit, he didn’t leave without imparting some knowledge first.

We were proud to stand alongside some of our inspirational supporters at the House of Commons today to press for better UK-wide services for children with life-limiting illnesses